Patent Document ID: 20050059598
Application ID: 10939111
Patent Flag: 0

Claim One:
1. A method for treating a subject having insulin-like growth factor-1 deficiency (IGFD) comprising; administering to a human pediatric subject an effective amount of insulin like growth factor-1 (IGF-1), wherein the subject is characterized as follows: at the time of treatment or prior to initial treatment with IGF-1, has or had a height at least about 2 standard deviations (SD) below the normal mean height for a subject of the same age and gender, and at the time of treatment or prior to initial treatment with IGF-1, has or had a blood level of IGF-1 at least about −1 SD below normal mean levels for a subject of the same age and gender, wherein the subject does not have Laron syndrome or partial growth hormone insensitivity syndrome, and wherein said administering is effective to treat IGFD in the subject.